A laboratory error at Milan’s San Raffaele Hospital resulted in an embryo being implanted into a woman who was not its intended recipient, prompting the clinic to suspend all assisted‑reproduction services pending a full investigation.
Test‑tube mix‑up at San Raffaele
According to reports from Italian media outlets including italianismo.com.br and L'Unione Sarda, a technician inadvertently swapped two test tubes during a routine IVF procedure. The mistake went unnoticed until after the embryo transfer, when the patient discovered that the pregnancy was not biologically linked to her and her partner.
A mistaken test‑tube swap resulted in the wrong embryo being implanted at the San Raffaele Hospital in Milan.
The woman, whose identity has been protected, had undergone a standard in‑vitro fertilisation cycle at the private clinic. When prenatal testing revealed a genetic mismatch, the clinic confirmed that an embryo belonging to another couple had been used. The error is the first documented case of its kind in Italy and has ignited a national debate over the oversight of fertility clinics.
Regulatory response and broader implications
Following the discovery, San Raffaele Hospital voluntarily halted all IVF and related procedures while it conducts an internal audit. The Italian Ministry of Health has been notified and is expected to issue an official directive on the matter. Health authorities have indicated that the incident may lead to stricter licensing requirements for laboratories handling gametes and embryos.
Italy’s assisted‑reproduction sector operates under some of the strictest European regulations, limiting the number of cycles per patient and prohibiting certain practices such as embryo donation. The mix‑up therefore raises concerns about compliance with these rules and the adequacy of existing quality‑control protocols.
Local political figures have also weighed in. Milan’s mayor, Vannacci, who recently launched a national political platform with Carmelo Burgio, said the case underscores the need for “greater transparency and accountability” in private healthcare. While the mayor’s involvement is primarily symbolic, it reflects the story’s prominence as Italy’s top domestic news item this week.
Patient advocacy groups have called for compensation for the affected couple and for the establishment of a national registry to track IVF outcomes. Some experts warn that the incident could erode public confidence in assisted‑reproduction, a field already facing criticism for high costs and limited access.
San Raffaele Hospital has not released the names of the medical staff involved, but it has pledged full cooperation with any external audit. The clinic’s director, speaking on condition of anonymity, emphasized that “the safety and trust of our patients are paramount” and that corrective measures will be implemented before services resume.
The case is being monitored by the European Society of Human Reproduction and Embryology, which has previously issued guidelines on laboratory best practices. If the investigation uncovers systemic failures, Italy could see alignment with broader European calls for stricter oversight of reproductive technologies.
